It suggests that JMJD1B and PRMT5 may also cooperatively regulate the dynamics of arginine methylation status of non-histone proteins such as transcription regulators to control gene expression for hematopoiesis and MDS avoidance. The gene discussed is PRMT5; the disease is myelodysplastic syndrome.